1.
Rossato P, Federti E, Matte A, Glantschnig H, Canneva F, Schuster M, Coulibaly S, Schrenk G, Voelkel D, Dockal M, Plaimauer B, Andolfo I, Iolascon A, Rottensteiner H, Gritsch H, Scheiflinger F, Hoellriegl W, Franceschi LD. Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease. Haematologica 2022;107(11):2650-2660; https://doi.org/10.3324/haematol.2021.280233.